XML 28 R15.htm IDEA: XBRL DOCUMENT v3.5.0.1
Stock Options, Restricted Shares and Warrants
12 Months Ended
Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK OPTIONS, RESTRICTED SHARES AND WARRANTS
STOCK OPTIONS, RESTRICTED SHARES AND WARRANTS
Orion has historically granted stock options and restricted stock under its 2003 Stock Option and 2004 Stock and Incentive Awards Plans (Plans). Under the terms of the Plans, Orion has reserved 13,500,000 shares for issuance to key employees, consultants and directors. The options generally vest and become exercisable ratably between one month and five years although longer and shorter vesting periods have been used in certain circumstances. Exercisability of the options granted to employees are generally contingent on the employees’ continued employment and non-vested options are subject to forfeiture if employment terminates for any reason. Options under the Plans are granted as non-qualified stock options (NQSO) and have a maximum life of 10 years. Certain non-employee directors have elected to receive stock awards in lieu of cash compensation pursuant to elections made under Orion’s non-employee director compensation program. The Plans also provide to certain employees accelerated vesting in the event of certain changes of control of Orion as well as under other special circumstances.
In May 2013, the Compensation Committee of the Board of Directors changed Orion's long-term equity incentive grant policy so that only restricted shares are issued to all employees under the Plans instead of stock options. The restricted shares are settled in Company stock when the restriction period ends. Compensation cost for restricted shares granted to employees is recognized ratably over the vesting term, which is typically between three to five years, although on occasion, the vesting term may be one year or less. Settlement of the shares is contingent on the employees’ continued employment and non-vested shares are subject to forfeiture if employment terminates for any reason. In fiscal 2016, an aggregate of 795,805 restricted shares were granted valued at a price per share between $1.34 and $2.62, which was the closing market price as of each grant date. In fiscal 2015, an aggregate of 410,496 restricted shares were granted valued at a price per share between $4.16 and $7.23, which was the closing market price as of each grant date. In fiscal 2014, an aggregate of 526,663 restricted shares were granted valued at a price per share between $2.41 and $6.97, which was the closing market price as of each grant date.
In fiscal 2016, Orion granted 35,290 shares from the 2004 Stock and Incentive Awards Plan to certain non-employee directors who elected to receive stock awards in lieu of cash compensation. The shares were valued ranging from $1.20 to $2.62 per share, the closing market price as of the issuance dates. Additionally, during fiscal 2016, Orion issued 2,500 shares to a consultant as part of a consulting compensation agreement. The shares were valued at $2.00 per share, the closing market price as of the issuance date. In fiscal 2015, Orion granted 27,931 shares from the 2004 Stock and Incentive Awards Plan to certain non-employee directors who elected to receive stock awards in lieu of cash compensation. The shares were valued ranging from $4.20 to $5.23 per share, the closing market price as of the issuance dates. In fiscal 2014, Orion granted 33,641 shares from the 2004 Stock and Incentive Awards Plan to certain non-employee directors who elected to receive stock awards in lieu of cash compensation. The shares were valued ranging from $2.41 to $5.73 per share, the closing market price as of the issuance dates.
In fiscal 2014, Orion recorded $200,000 of stock-based compensation related to the deferred consideration for employee Harris Shareholders resulting from the Harris acquisition.
The following amounts of stock-based compensation were recorded (dollars in thousands): 
 
Fiscal Year Ended March 31,
 
2016
 
2015
 
2014
Cost of product revenue
$
36

 
$
50

 
$
70

General and administrative
1,148

 
1,056

 
1,025

Sales and marketing
235

 
360

 
485

Research and development
43

 
33

 
13

 
$
1,462

 
$
1,499

 
$
1,593

















The number of shares available for grant under the plans were as follows:
Available at March 31, 2013
1,632,778

Granted stock options
(305,544
)
Granted shares
(33,641
)
Restricted Shares
(526,663
)
Forfeited restricted shares
69,375

Forfeited stock options
455,691

Available at March 31, 2014
1,291,996

Granted stock options

Granted shares
(27,931
)
Restricted Shares
(410,496
)
Forfeited restricted shares
74,957

Forfeited stock options
150,074

Available at March 31, 2015
1,078,600

Granted stock options

Granted shares
(64,960
)
Restricted shares
(795,805
)
Forfeited restricted shares
206,471

Forfeited stock options
363,380

Available at March 31, 2016
787,686


The following table summarizes information with respect to outstanding stock options: 
 
Number of
Shares
 
Weighted
Average Exercise
Price
 
Weighted
Average Fair
Value of
Options
Granted
 
Aggregate Intrinsic
Value
Outstanding at March 31, 2013
3,312,523

 
$
3.42

 
1.23

 
 
Granted
305,544

 
$
1.98

 
 
 
 
Exercised
(446,059
)
 
$
2.25

 
 
 
 
Forfeited
(455,691
)
 
$
3.26

 
 
 
 
Outstanding at March 31, 2014
2,716,317

 
$
3.43

 
1.32

 
 
Granted

 
$

 
 
 
 
Exercised
(139,407
)
 
$
2.46

 
 
 
 
Forfeited
(150,074
)
 
$
3.13

 
 
 
 
Outstanding at March 31, 2015
2,426,836

 
$
3.50

 

 
 
Granted

 
$

 
 
 
 
Exercised
(46,410
)
 
$
2.09

 
 
 
 
Forfeited
(363,380
)
 
$
4.68

 
 
 
 
Outstanding at March 31, 2016
2,017,046

 
$
3.32

 

 
$

Exercisable at March 31, 2016
1,811,146

 
 
 
 
 
$


The aggregate intrinsic value represents the total pre-tax intrinsic value, which is calculated as the difference between the exercise price of the underlying stock options and the fair value of Orion’s closing common stock price of $1.39 as of March 31, 2016.



The following table summarizes the range of exercise prices on outstanding stock options at March 31, 2016: 
 
March 31, 2016
 
Outstanding
 
Weighted Average Remaining Contractual Life (Years)
 
Weighted Average Exercise Price
 
Vested
 
Weighted Average Exercise Price
$1.62 - 2.20
684,476

 
4.93
 
$1.98
 
558,776

 
$1.98
$2.41 - 2.75
373,144

 
6.24
 
2.45
 
360,744

 
2.44
$2.86 - 4.28
719,971

 
4.07
 
3.41
 
652,171

 
3.44
$4.49 - 4.76
25,400

 
2.40
 
4.64
 
25,400

 
4.64
$5.35 - 5.44
77,204

 
3.03
 
5.39
 
77,204

 
5.39
$9.00
27,000

 
1.87
 
9.00
 
27,000

 
9.00
$10.14 - 11.61
109,851

 
1.66
 
10.87
 
109,851

 
10.87
 
2,017,046

 
4.54
 
$3.32
 
1,811,146

 
$3.43

During fiscal 2016, Orion granted restricted shares as follows (which are included in the above stock plan activity tables):
Balance at March 31, 2015
704,688

Shares issued
795,805

Shares vested
(240,633
)
Shares forfeited
(206,471
)
Shares outstanding at March 31, 2016
1,053,389

Per share price on grant date
$1.34-2.62

Compensation expense
$
1,306,191


As of March 31, 2016, the weighted average grant-date fair value of restricted shares granted was $2.06.
Unrecognized compensation cost related to non-vested common stock-based compensation as of March 31, 2016 is as follows (dollars in thousands): 
Fiscal 2017
$
1,113

Fiscal 2018
771

Fiscal 2019
274

Fiscal 2020
72

Fiscal 2021
12

Thereafter

 
$
2,242

Remaining weighted average expected term
2.6 years


Orion previously issued warrants in connection with various stock offerings and services rendered. The warrants granted the holder the option to purchase common stock at specified prices for a specified period of time. No warrants were issued in fiscal 2016, 2015 or 2014. During fiscal 2015, all warrants outstanding for a total of 38,980 shares were exercised at $2.25 per share, and as a result, none remain outstanding.
A summary of warrant activity is as follows:
 
Number of
Shares
 
Weighted
Average
Exercise Price
Outstanding at March 31, 2013
38,980

 
$
2.25

Issued

 

Exercised

 
$

Cancelled

 
$

Outstanding at March 31, 2014
38,980

 
$
2.25

Issued

 

Exercised
(38,980
)
 
2.25

Cancelled

 

Outstanding at March 31, 2015 and March 31,2016

 
$